Hospice billing has never been simple, but it has become significantly less forgiving. In many markets, a single denied month of hospice per diem can be the difference between a stable cash position and scrambling to make payroll. Claim denials can lead to significant financial stress and lost revenue for home health and hospice agencies, as patient rejections result in delayed reimbursements and financial losses. At the same time, home health agencies are trying to manage PDGM, RAP/NOA rules, and rising audit activity, all while clinical teams are stretched thin.
When a Notice of Election is a day late, when a face-to-face encounter is documented incorrectly, or when sequential billing is broken, Medicare does not just delay payment. In many cases it refuses to pay at all. With CMS and the OIG publicly calling out improper payments and documentation gaps in hospice services, denials are no longer an occasional nuisance. They are a structural financial risk that leadership teams have to manage with the same discipline they apply to staffing and cost reporting.
Why Hospice Denials Look Different
Hospice sits inside the broader family of Medicare Prospective Payment Systems, but its reimbursement mechanics and denial patterns are distinct from IPPS, PDPM, or PDGM. Hospitals and SNFs manage episodic or case-mix adjusted payments. Hospice lives on a daily fixed rate tied to levels of care and strict eligibility rules.
That per diem structure creates a unique denial profile. A single eligibility denial can wipe out weeks or months of expected revenue, even when the interdisciplinary group has delivered appropriate care. Recent CMS data show that improper payment rates for hospice remain material, with non hospital-based hospice services posting an estimated improper payment rate of 6.8 percent and hospital-based programs closer to 10.8 percent in the latest reporting period.1 These dollars are not theoretical; they reflect documentation and billing decisions that auditors can and do overturn later in the revenue cycle.
At the same time, CMS has expanded targeted oversight in key states. For example, in California, Nevada, Arizona, and Texas, enhanced prepayment review for new hospices recently produced a 40 percent denial rate on reviewed claims, with nearly half a million dollars in payments denied in early results alone.2 That level of scrutiny is a clear signal that hospices should expect more edits, more record requests, and more detailed questions about eligibility and related conditions.
The core challenge is that hospice denials are rarely about a single keystroke. They often trace back to upstream processes: how benefit periods are tracked, how face-to-face encounters are scheduled and documented, how NOEs are entered, and how clinical narratives are written under time pressure. Effective denial management is therefore less about heroic appeals and more about building a predictable workflow across clinical, intake, and billing teams.
The Current Denial Landscape: What Auditors Are Looking For
Across MACs and audit programs, a few themes show up over and over again in hospice denial findings.
First, eligibility documentation remains a primary driver of denials. CMS' hospice compliance guidance emphasizes that certifications must not only state that the patient is terminally ill with a life expectancy of six months or less, but must also include specific clinical findings and a brief narrative that ties those findings to the prognosis.1 The hospice must obtain written certification and document it in the clinical record before submitting a claim to the MAC.
Second, Notices of Election and benefit period transitions are under close review. Industry analyses of recent Medicare audits show that invalid or late NOEs account for a large share of hospice denials, alongside deficiencies in face-to-face encounters beginning with the third benefit period. Common issues include NOEs submitted outside the required window, incorrect effective dates, missing signatures, and incomplete documentation of face-to-face visits.
Third, billing sequence and claim structure are monitored more closely. MACs have been reminding hospices that claims must be submitted in strict sequential order, one per calendar month, and that the admission date must align with the effective date of the hospice election and remain consistent across continuing claims. One contractor has already implemented a claim edit that returns hospice continuous care claims when the admission date is incorrectly set equal to the "from" date of service, with specific return-to-provider reason codes guiding providers to correct admission dates based on the election effective date.3
Finally, the definition of what is covered by the hospice per diem is getting sharper. A 2025 OIG audit of acute care hospital outpatient services for hospice enrollees concluded that Medicare had improperly paid an estimated 190 million dollars over five years for services that should have been included in hospice per diem coverage.4 The report called for stronger edits and clarified guidance around services related to the terminal condition and related diagnoses.
Building a Hospice Denial Management Framework
A practical denial management framework for hospice and home health does not start with appeals. It starts with organizing work so that preventable errors are caught early, and unavoidable denials are handled quickly and consistently.
Most organizations benefit from thinking about denial management as part of a broader AR strategy. The same disciplines that reduce Days in AR under IPPS, PDPM, and PDGM also support hospice: front-end accuracy, clear ownership, and timely follow-through.
A simple hospice denial management framework typically includes clear intake and election controls, where every hospice episode begins with eligibility and a valid election; strong certification and recertification workflows with a shared calendar and tracking process; sequential billing discipline, following hospice-specific claim patterns including one claim per calendar month; centralized denial tracking through a categorized log by reason, payer, level of care, and location; and defined appeal pathways with templates, clinical support, and clear timelines.
Common Hospice Denial Types and How to Respond
While each payer has its own flavor, hospice denial reasons tend to fall into a few predictable buckets. Understanding these categories helps you design workflows that prevent them and respond efficiently when they occur.
Eligibility and prognosis denials are among the most financially significant. These denials argue that the documentation does not support a terminal prognosis of six months or less. From an operations perspective, the response starts well before the denial letter. Clinical teams should be trained to document measurable decline over time, connect findings to functional scales where relevant, and avoid copy forward language that suggests stability.
NOE and admission date denials are highly preventable but still common. Many organizations struggle with referral spikes, weekend admissions, and transitions from hospitals or SNFs that compress the five-day NOE window. A strong process includes daily NOE monitoring, back-up staff who can enter elections when primary staff are out, and periodic audits of NOE timeliness and accuracy.
Face-to-face and recertification denials are essentially clock management problems. The regulations require that the face-to-face encounter occur no more than 30 days before the start of the third and later benefit periods, with appropriate documentation and signatures. Many hospices address this by scheduling encounters earlier within the permissible window and building automated reminders.
Technical billing denials tied to sequencing, type of bill, or level of care can often be resolved more quickly. Examples include overlapping claims, incorrect revenue codes, or admission dates that do not match the election effective date. These issues are best controlled with robust claim scrubbing and edit review before submission.
Finally, coordination of benefits and related condition denials are becoming more visible. With greater attention on services furnished outside the hospice but related to the terminal diagnosis, hospices need clear protocols for arranging care with hospitals and other providers, and for documenting which services are covered under the hospice per diem. Denied claims lead to substantial financial losses for home healthcare companies, and the average cost to appeal a single denial can reach $181.
Designing a Denial Management Workflow That Fits Your Team
Each hospice and home health organization has its own structure, but the underlying components of a strong denial management workflow are similar.
Leadership should start by mapping the current state. That means tracing a claim from referral to payment and documenting each handoff. Where does the NOE get entered? Who verifies eligibility? When are certifications sent for signature? How are face-to-face encounters scheduled and tracked? Where are claim edits reviewed and cleared? This exercise often reveals that different teams have partial views and that no single person owns the full revenue cycle.
Once the current state is visible, agencies can design a future-state workflow that clarifies roles and removes redundant steps. From there, build a denial handling protocol. Denials should be routed to a small, trained group that understands both billing rules and clinical documentation.
Technology should support, not replace, these processes. Many agencies already have EMRs and billing platforms with denial dashboards, edit queues, and worklists. The value comes from configuring them to reflect your actual workflow.
Connecting Hospice Denials to Broader AR Performance
Hospice denial management does not sit in isolation from the rest of your AR. Home health and hospice programs share staff, systems, and leadership. When hospice denials spike, Days in AR often climb across the organization.
We often encourage providers to look at hospice denial metrics alongside core AR indicators that they already monitor for PPS programs. These include aging by payer and program, clean claim rates, first-pass resolution rates, and denial overturn percentages. When viewed together, these metrics reveal whether denials are a localized clinical documentation issue or a broader revenue cycle problem. High-performing agencies in 2026 use AI-driven tools and denial management bots to assign a Denial Risk Score to claims, catching errors before submission and reducing the likelihood of denials.
Agencies that have invested in AR clean-up projects often discover significant recoverable revenue in aged hospice claims. A systematic review of denials, partial payments, and underpayments can surface claims that are still appealable or correctable.
Practical Steps for Home Health and Hospice Leaders
For leadership teams balancing patient care, staffing, and PPS-driven reimbursement pressure, hospice denial management can feel like one more item on a long list. The way to make progress is to focus on a few concrete steps and measure the impact.
One practical step is to establish a recurring denial review meeting that includes finance, billing, and clinical representation. The goal is not to review every individual denial but to look at patterns. Which denial codes are driving the most dollars lost or delayed?
Another step is to invest in targeted training. Rather than broad, one-time education sessions, focus on the denial types that are most frequent or costly. Train clinical and billing staff on the latest Local Coverage Determinations (LCDs) and Medicare Conditions of Participation (CoPs) to prevent errors.
Finally, consider when it makes sense to bring in outside support. Many agencies find it practical to partner with specialized billing and AR teams that live in the details of PPS, PDGM, PDPM, and hospice rules every day.
How We Support Hospice Denial Management
Our work with hospice and home health organizations centers on stabilizing cash flow and reducing preventable denials. We bring the same accounting and AR perspective that informs our guidance on IPPS, PDPM, and PDGM, and apply it directly to hospice revenue cycles.
In practice, that often starts with a structured AR review. We examine current hospice receivables by payer, age, and denial type, and identify where process gaps are creating avoidable write-offs. From there, we help agencies design and implement a denial management workflow that their internal teams can sustain.
Because we operate as both a billing partner and an accounting firm, we also help leadership connect hospice denial trends to broader financial performance.
Conclusion: Turning Denial Management Into Routine Work
Hospice providers operate in a difficult environment. Fixed per-day payments, complex eligibility rules, and tightening oversight from CMS and auditors create real financial pressure. At the same time, agencies are managing the broader realities of Medicare PPS, PDGM, and PDPM across their service lines.
The good news is that hospice denial management does not have to be a mystery or a constant crisis. With a clear workflow, shared ownership across clinical and billing teams, and targeted use of technology and external expertise, you can turn denials from an unpredictable shock into a manageable part of your revenue cycle.
The path forward is not about eliminating denials entirely. It is about reducing preventable denials, resolving the rest quickly, and using what you learn to strengthen documentation and processes over time. That is how hospice and home health providers protect revenue, reduce Days in AR, and free up leadership to focus on patient care and strategic planning.